...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: possible catalyst(s)??

"My personal guess is liquidity in 2028"

If thats Don's plan also i turly hope he gets exactly what he deserves.IMO that timeframe will not be tolorated.

He's PO & brought many people to the brink already with all the bogus bs he's spread over the years & to date. 

Share
New Message
Please login to post a reply